IMKTA

Ingles Markets, Incorporated

There isn't enough reported data to score IMKTA yet.

IMKTA Fundamentals

MetricStatus
Stable
Stable
Healthy
Strong

IMKTA's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.

IMKTA PE Valuation

IMKTA has no meaningful PE right now: it lost money over the past year.

IMKTA Forward outlook

There aren't enough analyst estimates for IMKTA to show an outlook.

IMKTA Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $83.89 on Nov 12.

There is not enough scenario data to assess IMKTA's risk to reward.

IMKTA Earnings Per Share

Q3 2023: $11.15Q4 2023: $9.78Q1 2024: $9.33Q2 2024: $8.46Q3 2024: $5.55Q4 2024: $4.14Q1 2025: $3.26Q2 2025: $2.97
Q3 2023: $11.15Q4 2023: $9.78Q1 2024: $9.33Q2 2024: $8.46Q3 2024: $5.55Q4 2024: $4.14Q1 2025: $3.26Q2 2025: $2.97
QuarterTTM EPSYoY
Q2 2025$2.97-65%
Q1 2025$3.26-65%
Q4 2024$4.14-58%
Q3 2024$5.55-50%
Q2 2024$8.46-30%
Q1 2024$9.33-29%
Q4 2023$9.78-33%
Q3 2023$11.15-23%

IMKTA's earnings per share have fallen from their peak: $2.97 over the past year, against $14.66 in early 2022.

IMKTA Quarterly Revenue

Q3 2023: $1.6BQ4 2023: $1.5BQ1 2024: $1.4BQ2 2024: $1.4BQ3 2024: $1.4BQ4 2024: $1.3BQ1 2025: $1.3BQ2 2025: $1.3BQ3 2025: $1.4BQ4 2025: $1.4BQ1 2026: $1.3BQ2 2026: $1.4B
Q3 2023: $1.6BQ4 2023: $1.5BQ1 2024: $1.4BQ2 2024: $1.4BQ3 2024: $1.4BQ4 2024: $1.3BQ1 2025: $1.3BQ2 2025: $1.3BQ3 2025: $1.4BQ4 2025: $1.4BQ1 2026: $1.3BQ2 2026: $1.4B
QuarterRevenueYoY
Q2 2026$1.4B+1.6%
Q1 2026$1.3B-1.8%
Q4 2025$1.4B+6.6%
Q3 2025$1.4B-2.1%
Q2 2025$1.3B-3.4%
Q1 2025$1.3B-2.6%
Q4 2024$1.3B-13%
Q3 2024$1.4B-12%

IMKTA's revenue grew through 2024 and has held roughly level since: $1.4B last quarter, up 1.6% from the same quarter a year ago.

IMKTA Free Cash Flow

Q3 2023: $53MQ4 2023: −$48MQ1 2024: $35MQ2 2024: $59MQ3 2024: $5MQ4 2024: −$81MQ1 2025: $39MQ2 2025: $45MQ3 2025: $37MQ4 2025: $2MQ1 2026: $67MQ2 2026: $44M
Q3 2023: $53MQ4 2023: −$48MQ1 2024: $35MQ2 2024: $59MQ3 2024: $5MQ4 2024: −$81MQ1 2025: $39MQ2 2025: $45MQ3 2025: $37MQ4 2025: $2MQ1 2026: $67MQ2 2026: $44M
QuarterFree cash flowYoY
Q2 2026$43.6M-3.9%
Q1 2026$67.1M+73%
Q4 2025$2.1M+$83.5M
Q3 2025$36.8M+577%
Q2 2025$45.4M-23%
Q1 2025$38.9M+10%
Q4 2024-$81.4M-$33.8M
Q3 2024$5.4M-90%

IMKTA still generates free cash flow, though less than at its 2020 peak: $150M over the past year.

IMKTA Total Shares

Q3 2023: 19MQ4 2023: 19MQ1 2024: 19MQ2 2024: 19MQ3 2024: 18MQ4 2024: 23MQ1 2025: 19MQ2 2025: 19MQ3 2025: 19MQ4 2025: 19MQ1 2026: 19MQ2 2026: 19M
Q3 2023: 19MQ4 2023: 19MQ1 2024: 19MQ2 2024: 19MQ3 2024: 18MQ4 2024: 23MQ1 2025: 19MQ2 2025: 19MQ3 2025: 19MQ4 2025: 19MQ1 2026: 19MQ2 2026: 19M
PeriodChange %Net change
Quarterly+0.3%+48.6K shares
1 year+0.3%+48.6K shares
3 years+0.3%+48.6K shares
5 years+0.3%+48.6K shares
Available history-5.3%-1.1M shares

IMKTA has 19M diluted shares, about the same as a year ago.

IMKTA Net Leverage

Q3 2023: 0.6xQ4 2023: 0.8xQ1 2024: 0.8xQ2 2024: 0.6xQ3 2024: 0.8xQ4 2024: 1.2xQ1 2025: 1.1xQ2 2025: 1.0xQ3 2025: 0.6xQ4 2025: 0.7xQ1 2026: 0.4xQ2 2026: 0.3x
Q3 2023: 0.6xQ4 2023: 0.8xQ1 2024: 0.8xQ2 2024: 0.6xQ3 2024: 0.8xQ4 2024: 1.2xQ1 2025: 1.1xQ2 2025: 1.0xQ3 2025: 0.6xQ4 2025: 0.7xQ1 2026: 0.4xQ2 2026: 0.3x
QuarterNet LeverageStatus
Q2 20260.3xVery low
Q1 20260.4xVery low
Q4 20250.7xVery low
Q3 20250.6xVery low
Q2 20251.0xVery low
Q1 20251.1xHealthy
Q4 20241.2xHealthy
Q3 20240.8xVery low

IMKTA's net debt is less than a year of its operating earnings (EBITDA).

IMKTA Weekly Momentum

MetricValueStatus
RSI47.2Neutral
Stochastic28.5Neutral

IMKTA's weekly RSI is 47 (neutral) and its Stochastic is 29 (neutral).

IMKTA PE vs Consumer Defensive Sector

MetricIMKTASector medianRelative
PEN/A19x—

IMKTA has no meaningful PE right now: it lost money over the past year.

IMKTA Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$85.11.4% below
20 week MA$85.92.4% below
50 week MA$84.50.7% below
100 week MA$75.112% above
200 week MA$77.18.8% above

IMKTA has slipped below its 8-, 20- and 50-week averages, though it's still 8.8% above its 200-week average.

IMKTA Yearly ROI

YearStart priceEnd priceROI
2020$47.7$40.7-15%
2021$40.7$87.2+114%
2022$87.2$99.2+14%
2023$99.2$86.4-13%
2024$86.4$65.3-24%
2025$65.3$70.3+7.6%
2026 YTD$70.3$83.9+19%

IMKTA has finished lower in three of the last six years. It's up 19% so far in 2026.

Give your agent the market.

Get API key